Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $115.70 | $25.44 | 354.79% | 218.30x | 55.06x | 14.68x | 17.72x | 1.58x | $106.92M | 0.88% | $705.78M | 6.70 | $12.41B | 1,581.31 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.84 | $8.65 | 175.51% | 113.52x | 55.44x | 6.71x | 13.58x | 0.98x | $39.15M | 1.26% | $220.58M | 1.69 | $3.08B | 67.77 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $258.00 | $83.91 | 207.49% | 42.30x | 38.03x | 7.18x | 25.49x | 1.49x | $793.95M | 2.30% | $1.35B | 10.14 | $35.80B | 30.36 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.52 | $18.33 | 328.41% | 73.38x | 67.17x | 7.24x | 9.37x | 1.87x | $182.84M | 3.00% | $654.15M | 8.43 | $5.96B | 49.68 | ||
| KRYS | KRYSTAL BIOTECH INC | $348.09 | $89.20 | 290.24% | 42.09x | 44.59x | 23.34x | 7.58x | 2.23x | $257.78M | 2.51% | $1.36B | 46.03 | $9.88B | 42.37 | ||
| VCEL | VERICEL CORP | $38.99 | $8.46 | 360.85% | 81.23x | 69.66x | 6.50x | 5.40x | 1.99x | $61.66M | 3.10% | $370.04M | 7.25 | $1.96B | 44.58 | ||
| HALO | HALOZYME THERAPEUTICS INC | $107.39 | $71.85 | 49.47% | 30.17x | 11.89x | 7.57x | 84.91x | 0.62x | $806.22M | 6.40% | $143.54M | 1.22 | $14.17B | 19.72 | ||
| RPRX | ROYALTY PHARMA PLC | $60.59 | $38.11 | 59.00% | 32.23x | 11.31x | 10.63x | 3.56x | 0.65x | $2.92B | 10.84% | $9.79B | 21.99 | $42.99B | 36.55 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $64.41 | $19.93 | 223.14% | 169.50x | 22.12x | 3.66x | 1.97x | 1.11x | $738.18M | 5.92% | $6.32B | 32.68 | $15.78B | 40.91 | ||
| TECH | BIO-TECHNE CORP | $72.25 | $17.34 | 316.69% | 61.75x | 34.60x | 9.27x | 5.37x | 1.94x | $263.22M | 2.34% | $2.11B | 13.52 | $11.35B | 32.66 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.04 | $8.05 | 49.48% | 12.67x | 11.07x | 5.23x | 3.28x | 1.11x | $82.01M | 11.51% | $217.65M | 3.68 | $571.16M | 7.39 | ||
| TGTX | TG THERAPEUTICS INC | $54.65 | $23.73 | 130.35% | 17.74x | 54.99x | 9.69x | 13.85x | 1.98x | $17.39M | 0.23% | $604.08M | 4.26 | $8.63B | 62.02 | ||
| ADMA | ADMA BIOLOGICS INC | $9.45 | $7.38 | 27.97% | 13.13x | 11.88x | 4.21x | 5.19x | 0.77x | $116.47M | 5.40% | $408.21M | 1.79 | $2.18B | 9.35 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $241.31 | $188.37 | 28.11% | 15.81x | 9.44x | 3.31x | 3.26x | 0.66x | $1.62B | 10.62% | $4.80B | 75.98 | $18.44B | 11.41 | ||
| EXEL | EXELIXIS INC | $58.33 | $31.71 | 83.96% | 17.73x | 17.66x | 6.01x | 7.84x | 1.17x | $1.17B | 8.01% | $1.84B | 7.35 | $14.34B | 13.18 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.17 | $6.29 | -81.40% | 8.36x | -3.96x | 1.44x | 1.54x | 0.07x | $19.58M | 28.89% | $44.20M | 0.76 | $19.40M | 2.54 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $288.05 | $90.94 | 216.74% | 28.60x | 30.49x | 19.89x | 5.94x | 2.16x | $130.62M | 2.26% | $967.52M | 48.22 | $5.87B | 21.03 | ||
| MDXG | MIMEDX GROUP INC | $4.68 | $1.51 | 210.25% | 117.00x | -33.36x | 1.95x | 3.16x | 1.11x | $44.50M | 6.43% | $216.00M | 1.46 | $563.53M | 24.71 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $521.12 | $161.05 | 223.58% | 30.07x | 27.11x | 10.50x | 6.52x | 2.14x | $3.80B | 2.87% | $20.25B | 79.81 | $127.92B | 23.24 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $807.65 | $451.43 | 78.91% | 19.26x | 14.48x | 5.34x | 2.62x | 1.03x | $3.76B | 4.53% | $31.71B | 308.48 | $83.40B | 14.50 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $41.62 | $31.85 | 30.69% | 13.25x | 9.98x | 2.51x | 2.43x | 0.79x | $354.90M | 14.72% | $999.24M | 17.25 | $2.03B | 7.24 | ||
| UTHR | UNITED THERAPEUTICS CORP | $506.82 | $202.74 | 149.99% | 16.76x | 18.92x | 6.84x | 3.40x | 2.90x | $1.09B | 5.06% | $6.40B | 150.24 | $19.93B | 11.89 | ||
| INCY | INCYTE CORP | $126.01 | $62.34 | 102.13% | 15.52x | 35.54x | 4.34x | 4.03x | 1.74x | $1.92B | 7.61% | $6.34B | 31.66 | $21.59B | 10.44 | ||
| VCYT | VERACYTE INC | $43.86 | $7.17 | 512.04% | 30.46x | 41.95x | 6.24x | 2.54x | 121.15x | $165.99M | 4.73% | $1.39B | 17.36 | $3.26B | 23.37 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.